Intravenous Dexmedetomidine in Cesarean Section Under Spinal Anesthesia

• Status: Completed
• Trial end date: 2019-11-19
• Target enrollment: 0
• Participant gender: Female

Summary

The present study hypothesized that intravenous dexmedetomidine use during spinal anesthesia for cesarean section has a beneficial influence on hemodynamic stability and epigastric pain together with satisfactory analgesic effects and excellent safety profile for the mother and the newborn.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Egyptian Biomedical Research Network
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• Full-term pregnancy and American Society of Anesthesiologists (ASA) physical status I/II in women scheduled for elective cesarean section

Exclusion Criteria:

• Severe hepatic or renal disease

• Severe cardiopulmonary disease

• Thyroid disorders multiple allergies prematurity

• Known fatal abnormality

• Known chronic gastrointestinal problems with epigastric pain e.g. peptic ulcer and reflux esophagitis.